NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BRL Medicine Inc.

BRL Medicine Inc.

Private
ShanghaiHealthcare & Life Scienceshttps://brlmed.com/

Last Round

Series B

Extension

Nov 25, 2024

Total Funding Raised

$55.32M

Company Overview

BRL Medicine Inc. is a biotechnology company that develops gene-editing and cell-therapy platforms for the treatment of genetic diseases, cancer, and immune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapygene therapyCAR-TCRISPRgene editinghematopoietic stem cellgenomic medicinecell engineeringallogeneic cell therapybiotechnologyprecision medicinenext-gen biotechnon-viral integrationhemoglobinopathiesclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BRL Medicine Inc. Comparables

Compare BRL Medicine Inc. with similar companies based on industry and business-model similarity.

BRL Medicine Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EdiGene
87%
Beijing Yimiao Shenzhou Pharmaceutical Technology
83%
BriSTAR Immunotech
83%

BRL Medicine Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionNov 25, 2024
Series BNov 14, 2022
GrantDec 1, 2021
Series A ExtensionJun 1, 2018
Series AJun 1, 2016

BRL Medicine Inc. Investors

Notable investors and investment history

BRL Medicine Inc. investors
InvestorRounds
Oriental Fortune CapitalSeries A, Series B
Shanghai Municipal People's GovernmentGrant
Gopher Asset ManagementSeries B
Tasly CapitalSeries B
华润资本Series A Extension
Shanghai Free Trade Zone FundSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 30, 2024

    Monthly visitors increased 188% MoM, reaching 4.9K.

BRL Medicine Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BRL Medicine Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BRL Medicine Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range34
Year Founded2013
Last FundingNov 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.